ODDB.org: Open Drug Database

Sanofi Pasteur MSD AG - HBVAXPRO 5, Injektionssuspension

Swissmedic Registration	00662	Sequence	01
Product name	HBVAXPRO 5	Description	Injektionssuspension
ATC-Classification	J07BC01	ATC-Description	Hepatitis B, Purified Antigen
Introduction of Sequence	20.08.2002

Composition

hepatitidis B virus antigenum ADNr 5 µg, aluminium ut aluminii hydroxyphosphas sulphas amorphus, natrii boras, natrii chloridum, aqua ad iniectabilia q.s. ad suspensionem pro 0.5 ml.

Packungsbestandteile

Galenic Form

Injection suspension

Excipiens

Active Agent	Dose
Hepatitidis b Virus Antigenum Adnr	5 µg

Inactive agents
Alumine
Natrii Boras
Sodium Chloride

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
011	ampoule(s)	22.42	42.10	B		Yes

2025	©ywesee GmbH